Loading clinical trials...
Loading clinical trials...
A Single Dose, Randomized Study to Assess the Relative Bioavailability of Two Formulations and Food Effect on GSK1265744 in Healthy Male and Female Subjects
Conditions
Interventions
GSK1265744 10 mg oral solution
GSK1265744 5 mg tablet
+1 more
Locations
1
United States
GSK Investigational Site
Buffalo, New York, United States
Start Date
June 1, 2008
Primary Completion Date
August 1, 2008
Completion Date
August 1, 2008
Last Updated
April 2, 2012
NCT04929028
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT05897099
Lead Sponsor
ViiV Healthcare
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions